SPC334
Tagraxofusp
Status:
VeittApplication date:
10.5.2021Application published:
15.6.2021Grant published:
15.12.2022
Max expiry date:
6.9.2032Medicine name:
ElzonrisMedicine for children:
No
Timeline
Today
10.5.2021Application
15.6.2021Publication
15.12.2022Registration
6.9.2032Expires
Marketing license
IS authorization number:
EU/1/20/1504/001Date:
19.1.2021
Foreign authorization number:
EU/1/20/1504Date:
7.1.2021
Owner
Name:
Scott & White Memorial HospitalAddress:
2401 South 31st Street, Temple, TX US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3207941